Skip to content
Independent analysis of NHS open data
PharmaInsight

Emtricitabine/Rilpivirine/Tenofovir disoproxil vs Valaciclovir

National NHS prescribing compared (Prescription Cost Analysis)
Data updated March 2026

Valaciclovir was dispensed 6,824.0× as often as Emtricitabine/Rilpivirine/Tenofovir disoproxil in March 2026 — 6,824 items versus 1 in England.

1items

Emtricitabine/Rilpivirine/Tenofovir disoproxil · March 2026

NHSBSA Prescription Cost Analysis

6,824items

Valaciclovir · March 2026

NHSBSA Prescription Cost Analysis

Figure 1. Emtricitabine/Rilpivirine/Tenofovir disoproxil versus Valaciclovir: national items dispensed by month

▬ Emtricitabine/Rilpivirine/Tenofovir disoproxil   ·   ╌ Valaciclovir

0 3k 7k Jan 2026 Mar 2026 Valaciclovir 1 Jan 2026: 2 Mar 2026: 1

Source: NHSBSA Prescription Cost Analysis, to March 2026

Emtricitabine/Rilpivirine/Tenofovir disoproxil versus Valaciclovir, March 2026
Measure Emtricitabine/Rilpivirine/Tenofovir disoproxil Valaciclovir
Items, March 2026 1 6,824
Items, last 12 months 3 76,064
Net ingredient cost, March 2026 £1,052 £399,058

See the full profile for Emtricitabine/Rilpivirine/Tenofovir disoproxil or Valaciclovir.